King To Seek Release From Consent Decree on Former Warner-Lambert Plant
Executive Summary
King Pharmaceuticals plans to petition in August for relief from the consent decree placed on its Parkedale facility (Rochester, Mich.) formerly owned by Warner-Lambert, King states in a prospectus for its recent initial public offering.
You may also be interested in...
Parkedale Turns To Consultants After FDA Halts Fluogen Production
Parkedale Pharmaceuticals is drawing on advice from regulatory consultants The Biologics Consulting Group and regulatory legal counsel Arnold and Porter in "evaluating strategies pertaining to Fluogen," the company said.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011